“…Synthetic drosocin lacking O-glycosylation is less active than the native compounds, suggesting that the post-translational modification is necessary for full activity (Bulet et al, 1993; Bulet et al, 1999; Bulet et al, 1996; Gobbo et al, 2002; Hoffmann et al, 1999). Indeed, many studies have demonstrated that a variety of synthetic drosocin derivatives with varying sugar moieties maintain good antimicrobial activity, generally better than the unmodified form (Ahn et al, 2011a; Ahn et al, 2011b; Gobbo et al, 2002; Lele et al, 2015a; Marcaurelle et al, 1998; Otvos et al, 2000; Rodriguez et al, 1997; Talat et al, 2011). Although NMR and CD experiments suggest that both the modified and unmodified forms of drosocin adopt extended conformations in solution (Bulet et al, 1996; Gobbo et al, 2002; Lele et al, 2015a; McManus et al, 1999; Talat et al, 2011), the presence of the modification has nevertheless been proposed to help drosocin maintain an extended conformation to facilitate binding to its intracellular target (Bulet et al, 1999; Gobbo et al, 2002; McManus et al, 1999).…”